CELLECTIS SA And Ozgene Pty Ltd Enter Into A License Agreement 
10/19/2005 5:09:34 PM

Romainville, France and Perth, Australia - July the 12th, 2005 - Cellectis S.A., the genome engineering company, announced today that it entered into an agreement with Ozgene Pty Ltd. by which Cellectis granted Ozgene a worldwide non-exclusive commercial license under its patent family relating to a process for the specific replacement or insertion of a gene in an eukaryotic genome. Under this agreement, Ozgene obtained a license from Cellectis for creating, developing and selling mice for use in the course of its activities relating to mouse knock-ins. Financial terms and conditions of the agreement were not disclosed.